Dendrimer-drug conjugates

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10730999
APP PUB NO 20170189543A1
SERIAL NO

15315690

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention generally relates to macromolecules of dendrimer-drug conjugates. In particular, the invention relates to macromolecules comprising a pharmaceutically active agent, such as a protein or peptide, attached to a core of a dendrimer derived from branched building units, such as lysine or lysine analogues. The invention also relates to the synthesis of the dendrimers and macromolecules, and the use of such macromolecules, particularly in therapeutic applications, and pharmaceutical compositions comprising them.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
STARPHARMA PTY LTDBAKER BUILDING 75 COMMERCIAL ROAD PRAHAN VICTORIA 3004

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bernhard, Oliver Dorfprozelten, DE 1 4
Giannis, Michael Point Cook, AU 5 8
Owen, David James Kew, AU 11 10
Stanislawski, Pauline Pascoe Vale, AU 8 59

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 4, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 4, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00